CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising adoption of minimally invasive surgical procedures
4.1.2. Increasing target disease incidence
4.1.3. Favourable reimbursement scenario and increasing guidewires applications
4.2. Market Restraints & Challenges
4.2.1. The high cost of surgical guidewires
4.2.2. Lack of skilled surgeons to conduct the minimally invasive surgeries
4.3. Market Opportunities
4.3.1. Government initiatives to control the burden of healthcare-associated infections (HAIS)
4.3.2. Increasing healthcare expenditure across emerging nations
CHAPTER 5. GLOBAL GUIDEWIRES MARKET – BY MATERIAL
5.1. Nitinol Guidewires
5.2. Hybrid Guidewires
5.3. Stainless Steel Guidewires
CHAPTER 6. GLOBAL GUIDEWIRES MARKET – BY PRODUCT
6.1. Diagnostic Guidewires
6.1.1. Hydrophobic Diagnostic Guidewires
6.1.2. Hydrophilic Diagnostic Guidewires
6.2. Surgical Guidewires
6.2.1. Hydrophobic Surgical Guidewires
6.2.2. Hydrophilic Surgical Guidewires
CHAPTER 7. GLOBAL GUIDEWIRES MARKET – BY APPLICATION
7.1. Otolaryngology Applications
7.2. Gastroenterology Applications
7.3. Oncology Applications
7.4. Urology Applications
7.5. Vascular Applications
7.6. Neurology Applications
7.7. Cardiology Applications
CHAPTER 8. GLOBAL GUIDEWIRES MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL GUIDEWIRES MARKET - COMPANY PROFILES
9.1. Abbott Laboratories Pharmaceutical Company
9.2. Johnson & Johnson Pharmaceutical Company
9.3. Asahi Intecc Co, Ltd.
9.4. Terumo Corporation
9.5. Medtronic PLC
9.6. B. Braun Melsungen
9.7. Boston Scientific Corporation
9.8. Cardinal Health, Inc.
9.9. Olympus Corporation
9.10. Angiodynamics, Inc.
9.11. Cook Group Incorporated
9.12. Merit Medical Systems
9.13. Teleflex Incorporated
9.14. Stryker Corporation
9.15. C.R. Bard, Inc.
CHAPTER 10. GLOBAL GUIDEWIRES MARKET - COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
